Background Hepatocellular carcinoma (HCC) is the sixth most common cancer in the world
and the third leading cause of cancer-related death. Although the diagnostic scheme of HCC …

Our objective was to determine if supersonic shear wave elastography (SSWE) can detect
changes in stiffness of a breast cancer model under therapy. A human invasive carcinoma …

Objectives Monitoring the early treatment effect of sorafenib in advanced hepatocellular
carcinoma (HCC) patients is a diagnostic challenge. In a previous study, we reported the …

Prior to the introduction of sonography 40 years ago, the only non-invasive information
easily available to clinicians managing patients with suspected liver disease were the …

Background Development of escape pathways from antiangiogenic treatments was reported
to be associated with enhanced tumor aggressiveness and rebound effect was suggested …

Background: Hepatocellular carcinoma (HCC) is the sixth most common cancer in the world
and the third leading cause of cancer-related death. Although the diagnostic scheme of HCC …

Sorafenib, which is a novel targeted agent, plays an important role in treating advanced
hepatocellular carcinoma (HCC) through its antiangiogenic and antiproliferative effects …

Herewith and as part of celebrating the edition of a Felicitations Volume in honour of our
esteemed colleague and friend Professor Luigi Bolondi, who has retired after a long and …

Portal hypertension (PH) is a major determinant of the outcome of patients with
hepatocellular carcinoma (HCC) undergoing curative treatment, especially resection. Liver …

The successful collaboration among Ultraschall in der Medizin/European Journal of
Ultrasound (UiM/EJU), DEGUM, ÖGUM and SGUM as well as Thieme Verlag was confirmed …